ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1861

T Cells with IL-17A+ Signature in Psoriatic Arthritis Are of Different Subpopulations and Are Polyfuntional

Siba Raychaudhuri1 and Smriti Raychaudhuri2, 1Division of Rheumatology, Allergy & Clinical Immunology, University of California School of Medicine, Davis, and VA Medical Center Sacramento, Sacramento, CA, 2VA Sacramento Medical Center, Davis, CA

Meeting: ACR Convergence 2020

Keywords: immunology, innate immunity, Psoriatic arthritis, T-Lymphocyte, TH17 Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: A variety of T cells such as Th1, Th2, Th9, Th17, NKT, MAIT, etc have been attributed to multiple autoimmune diseases.  In psoriatic arthritis (PsA) contributing role of the Th17 cells have been observed and lately success of IL17/IL-23 targeted therapies has further substantiated this. Here we will share our cumulative data on Th17 cells in PsA collected over last 2 decades. 

Methods: PBMCs and synovial fluid mononuclear cells (SFMCs) were collected from age/sex matched with active untreated PsA, rheumatoid arthritis (RA) and osteoarthritis patients (OA, n=50, each). Patients were recruited after proper IRB approval. Magnetically sorted CD3+ T cells were isolated from PBMCs and SFMCs; were activated (106 cells/ml) with anti-human CD3/CD28 antibody cocktail and cultured in RPMI medium for 5 days.  Hi-D FACS studies were performed; lymphocytes were gated first based on FSC and SSC, then CD3+CD11a+CD45RO+17A+ cells were gated. In these gated population MAIT cells were identified as CD3+CD161+Vα7.2TCR+ cells, γδ-T cells as CD3+ γδTCR+, NKT cells as CD3+CD161+ and αβ-T cells as αβTCR+. NKT cells (CD3+CD161+) were further gated for TCR Vα24-Jα18 (iNKT cell) ab positivity.

Results: In OA activated Effector Memory T Cells (TEM cells) were < 1%. We noticed a marked polyfunctionality in PBMC/SFMC T cells both in PsA and RA. In PsA SFMC, memory T cells (CD3+CD4+CD45RO+) had IL-17A+ (18+0.5%), IL-22+(7+0.3%) and IL-23R+ (8.5+0.5%) T cells compared to SFMC memory T cells of RA (6.8+0.3%, 2.5+0.5%, 2.1+0.7%, respectively; p< 0.001). TEM cells in PsA and RA at single cell level also produced IL-9 and TNF-α.

IL-17A+ TEM phenotypes in SFMC of PsA demonstrated both invariant and conventional αβT cell Immune response (Fig 1): αβTCR+ (79.8+0.9%), γδ TCR+ (1.5+0.2%), iNKT (15.5+1.1%) and MAIT (4.5+0.8%) cells. Majority of the αβTCR+ T cells were CD4+ ( >85%) whereas MAIT were predominantly CD8+ (~ 90%).

Conclusion: In PsA TEM cells were polyfunctional in respect to their cytokines (IL-9, IL-17A,IL-22, TNF-α)  however more skewed towards conventional activated memory αβTh17 cells. Our finding clearly suggests that TEM cells of adaptive as well as innate immune response produce IL-17A in PsA, but the major amount of IL-17A comes from the conventional CD4+ (αβTCR+) cells (~80%). The fact that synovial T cells of innate immune response also express IL-17A (~20%), suggest a bridge between adaptive and innate immune response.

Figure 1: IL-17A+ cells in peripheral blood and synovial fluid of PsA patients. Peripheral blood mononuclear cells (PBMC) and synovial fluid mononuclear cells (SFMC) were isolated from PsA (n=15) and stimulated with with anti-human CD3/CD28 antibody cocktail. Lymphocytes were gated first based on FSC and SSC, then CD3+CD11a+CD45RO+17A+ T cells were gated. αβ TCR+, γδ TCR+ T cells, iNKT and MAIT cells were identified in these gated CD3+CD11a+CD45RO+17A+. (A) Representative FACS plots showing the frequencies of different IL-17A+ immune cells in PsA. (B) Bar diagram (n=15) showing the frequencies of IL-17A producing αβ, NKT, γδ T cells and MAIT cells in PBMC and SFMC of PsA patients.


Disclosure: S. Raychaudhuri, AbbVie, 2, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sun Pharmaceutical Industries, Inc., 2, Amgen, 5, Eli Lilly, 5; S. Raychaudhuri, None.

To cite this abstract in AMA style:

Raychaudhuri S, Raychaudhuri S. T Cells with IL-17A+ Signature in Psoriatic Arthritis Are of Different Subpopulations and Are Polyfuntional [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/t-cells-with-il-17a-signature-in-psoriatic-arthritis-are-of-different-subpopulations-and-are-polyfuntional/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-cells-with-il-17a-signature-in-psoriatic-arthritis-are-of-different-subpopulations-and-are-polyfuntional/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology